D-Serine in Neuropsychiatric Disorders: New Advances
Figure 4
Effect of NMDAR-glycine site agonists on extrapyramidal symptoms as reflected in Simpson Angus Scale for Extrapyramidal Symptoms (SAS) change scores. Data are from glycine [61] and D-serine [62] studies. versus placebo. (Reproduced from [63]).